Bond.az White LogoBond.az Black Logo
→
EN ▾
AZENRU
Duolingo SWOT Analysis: Stock Faces AI Pivot ConcernsPIMCO warns central banks may tighten policyBTIG cuts Lightspeed price target to $12H.B. Fuller Offers 285p for AMSUArchitect: Restoration in Karabakh is unique synthesisEMA accepts Teva's long-acting olanzapine applicationStellantis unveils €60B strategic planBond.az: Live Ventures CEO Buys $55k in StockApplied Digital stock hits all-time high at $47.81STM stock hits 52-week high at 65.34Duolingo SWOT Analysis: Stock Faces AI Pivot ConcernsPIMCO warns central banks may tighten policyBTIG cuts Lightspeed price target to $12H.B. Fuller Offers 285p for AMSUArchitect: Restoration in Karabakh is unique synthesisEMA accepts Teva's long-acting olanzapine applicationStellantis unveils €60B strategic planBond.az: Live Ventures CEO Buys $55k in StockApplied Digital stock hits all-time high at $47.81STM stock hits 52-week high at 65.34
Personalize
Bond.az White LogoBond.az Black Logo
AZENRU

#schizophrenia

Latest news and interesting information about schizophrenia.

EMA accepts Teva's long-acting olanzapine application
Today / 17:42
|
520

EMA accepts Teva's long-acting olanzapine application

EMA accepts Teva and Medincell's application for long-acting injectable olanzapine TEV-749 for schizophrenia treatment. Learn more about this new formulation.

COMPANY →
0
...